Sophia Delicou: Recognizing Missed Clues and Advancing Early Clinical Suspicion of Adult Haemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Haematology, adding:
”We are pleased to share our team’s latest publication in the European Journal of Haematology:
‘Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework’
This work highlights an important and often under-recognized clinical challenge: the delayed diagnosis of haemoglobinopathies in adulthood.
Patients are frequently misclassified as having iron deficiency anaemia, leading to inappropriate iron supplementation, prolonged diagnostic uncertainty, and delayed access to appropriate care and genetic counselling.
In our retrospective pilot study, key recurring features included persistent microcytosis, evidence of haemolysis, and lack of response to iron therapy.
We also propose a preliminary clinical suspicion framework, the Haemoglobinopathy Suspicion Score (HSS), as a hypothesis-generating tool requiring further validation.
The key message fully aligned with the mission of the Thalassaemia International Federation (TIF) is clear: early clinical suspicion of haemoglobinopathies in adults is essential to reduce diagnostic delays and improve patient outcomes.
Congratulations to the entire multidisciplinary team for this important contribution.”
Title: Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework
Authors: Sophia Delicou, Aikaterini Poulaki, Iliana Mani, Christos Savvidis, Aikaterini Xydaki, Maria Moraki, Constantina Aggeli, Ioannis Ilias, John Koskinas

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders